Genetic risk models in age-related macular degeneration

Advances in Experimental Medicine and Biology

Volumn 801, Issue , 2014, Pages 291-300

  Grassmann, Felix ^a   Heid, Iris M ^a,b   Weber, Bernhard H F ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Age related macular degeneration; Cox regression; Genetic risk score; Logistic regression; Susceptibility

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ARTICLE; ENVIRONMENTAL FACTOR; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; LIFESTYLE; MEASUREMENT ACCURACY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VALIDATION STUDY; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; RETINA MACULA DEGENERATION; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACULAR DEGENERATION; MODELS, GENETIC; RISK FACTORS;

EID: 84904801829     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3209-8_37     Document Type: Article

References (25)

1. Congdon N, O'Colmain B, Klaver CCW, Klein R, Muñoz B et al (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477-485
2. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-572
3. Klein R, Klein BEK, Knudtson MD, Meuer SM, Swift M et al (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253-262
4. Solomon SD, Jefferys JL, Hawkins BS, Bressler NM, Bressler SB (2009) Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group. Retina 29:1080-1090
5. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417-1436
6. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321-327
7. Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BHF (2012) Modelling the genetic risk in age-related macular degeneration. PloS One 7:e37979
8. Klein RJ, Zeiss C, Chew EY, Tsai J, Sackler RS et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389
9. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458-462
10. Maller J, George S, Purcell S, Fagerness J, Altshuler D et al (2006) Common variation in three genes, including a non-coding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38:1055-1059
11. Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R et al (2007) Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med 4:e355
12. Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB (2008) C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PloS One 3:e2199
13. Seddon JM, Reynolds R, Maller J, Fagerness J a, Daly MJ et al (2009) Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 50:2044-2053
14. Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE (2009) Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 5:e1000337
15. Farwick A, Dasch B, Weber BHF, Pauleikhoff D, Stoll M et al (2009) Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study. Eye 23:2238-2244
16. Gibson J, Cree A, Collins A, Lotery A, Ennis S (2010) Determination of a gene and environment risk model for age-related macular degeneration. Br J Ophthalmol 94:1382-1387
17. Chen Y, Zeng J, Zhao C, Wang K, Trood E et al (2011) Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol 129:344-351
18. Klein ML, Francis PJ, Ferris FL, Hamon SC, Clemons TE (2011) Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol 129(12):1543- 1550
19. Hageman GS, Gehrs K, Lejnine S, Bansal AT, Deangelis MM et al (2011) Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genomics 5:420-440
20. Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B (2011) Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology 118:2203-2211
21. Spencer KL, Olson LM, Schnetz-Boutaud N, Gallins P, Agarwal A, et al (2011) Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration. PloS One 6:e17784
22. McCarthy LC, Newcombe PJ, Whittaker JC, Wurzelmann JI, Fries M a et al (2012) Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design. Am J Ophthalmol 154:568-578.e12
23. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247:2543-2546
24. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK et al (2011) A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 43:1232-1236
25. Ferris FL, Davis MD, Clemons TE, Lee L-Y, Chew EY et al (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123:1570-1574